Skip to main content
Diagnostics and screeningCancerProcedure

What this study is

This study assesses the incorporation of Multi-Cancer Detection (MCD) testing, designed to detect many types of cancer, into clinical practice to understand both its use and effect in real world practice conditions.

What's being tested

  • Blood Sample

    Intervention · PROCEDURE

    Up to 60 mL (about 4-5 Tbsp) of blood may be collected for an initial blood draw and up to 30 mL (about 2-3 Tbsp) may be collected for a second blood draw, 25-45 days after first blood draw. The research blood will be collected at the time of a clinical blood draw, if possible.

  • Surveys

    Intervention · OTHER

    Participants will complete surveys related to attitudes and beliefs around Multi-Cancer Detection testing.

Study details

Sponsor
Mayo Clinic
Conditions
Cancer
Enrolling
1,000 people
Starts
2025-05-07
Est. completion
2029-06-30
Record
View on ClinicalTrials.gov ↗